Catalytic amyloids: Is misfolding folding?

Liam R. Marshall, Ivan V. Korendovych

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


Originally regarded as a disease symptom, amyloids have shown a rich diversity of functions, including biologically beneficial ones. As such, the traditional view of polypeptide aggregation into amyloid-like structures being ‘misfolding’ should rather be viewed as ‘alternative folding.’ Various amyloid folds have been recently used to create highly efficient catalysts with specific catalytic efficiencies rivaling those of enzymes. Here we summarize recent developments and applications of catalytic amyloids, derived from both de novo and bioinspired designs, and discuss how progress in the last 2 years reflects on the field as a whole.

Original languageEnglish (US)
Pages (from-to)145-153
Number of pages9
JournalCurrent Opinion in Chemical Biology
StatePublished - Oct 2021


  • Amyloid
  • Catalysis
  • Peptide
  • Self-assembly

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry


Dive into the research topics of 'Catalytic amyloids: Is misfolding folding?'. Together they form a unique fingerprint.

Cite this